Banner

December 3, 2008

Crowdsourcing Drug Safety

iGuard Turns One

iGuard expected to draw 60,000 members in a year. Instead, it attracted 750,000. The coming shift in strategy—and genomics.

Electric Fruit On Hyperbolic Trees

New Nextrials Tools, Customer Wins

Nextrials is using the same technologies that make consumer websites interactive. A standards-centric supplier of electronic data capture talks about recent growth.

Who Should Not Recruit?

Clarification: Pfizer Site Strategy

A clarification to recent ClinPage coverage of Pfizer at DIA.

Parexel, EDC solution, DIA meeting

News For Friday

Plus items about Quintiles, Trialstat and BBK.

thumbnail
Crowdsourcing Drug Safety

iGuard Turns One

October 15, 2008

By SuzR

Hugo Stephenson is floored by the growth of iGuard, the consumer-oriented online medical monitoring service he started last year with financial support from Quintiles. iGuard turns one this month. When it was launched, Stephenson expected to have perhaps 60,000 people…

thumbnail
Electric Fruit On Hyperbolic Trees

New Nextrials Tools, Customer Wins

September 28, 2007

By Mark Uehling

No one ever accused electronic data capture (EDC) systems of glamour. They all have a certain tabular sameness. EDC may be a newly welcome, even essential technology in the pharmaceutical industry. But beautiful? Yes, actually. At least from Nextrials. Founded…

thumbnail
Who Should Not Recruit?

Clarification: Pfizer Site Strategy

July 11, 2007

By Mark Uehling

After a complaint from Pfizer, we’ve updated a recent story about DIA. There’s a link to our first story at the bottom of this article. It’s clear ClinPage accurately quoted Andy Lee, Pfizer’s vice president of clinical study and data…

thumbnail
Parexel, EDC solution, DIA meeting

News For Friday

June 15, 2007

By info@clinpage.com

At the Drug Information Association’s (DIA) 43rd Annual Meeting, June 17–21, 2007, in Atlanta, GA, experts from Parexel International, a major contract research organization, will present key topics. Dr. Alberto Grignolo, PhD, corporate vice president and general manager of drug…